Introduction
Despite relatively high contraceptive prevalence (61%) compared to other developing countries, Bangladesh continues to have low utilization of long term or permanent contraceptive methods, a high discontinuation rate 1 . Menstrual regulation has been part of Bangladesh's national family planning program since 1979. Indirect estimates suggest more than 1.2 million annual menstrual regulations (MRs) and induced abortions each year in Bangladesh 2 .
Maternal mortality in Bangladesh is 1.76 /1000 live birth, one fourth of these deaths are due to complication of induce abortion.
An estimated 56 million induced abortion occured each year worldwide 3 . The safety of procedure is therefore of global public health importance. Now medical abortion options have made more available to women in a variety of health care setting and home administration of medical abortion is acceptable 4 A medical abortion is said to be successful when the medication used, achieves complete expulsion of the products of conception, without the need of any surgical intervention 10 . Medical terminations are safe and effective alternative to surgical vacuum aspiration of uterus with high level of patient satisfaction 11 . Medical abortion allows the women to avoid an invasive procedure and to avoid significant exposure to anesthetic medications. Many women feel medical abortion to be the more "natural" option, like a miscarriage, and prefer being in the comfort of their own home for the process 12 .
Mifepristone (RU486) is a potent anti-progestin but when it is administered alone for early pregnancy termination, it results in incomplete expulsion in approximately 20% of women 13 . This relative lack of efficacy may be due to an insufficient increase in prostaglandin concentration in uterus to allow completion of termination 10 . 
Materials and Methods
Subjects for this prospective randomized cross sectional study were enrolled from outdoor patients (100 cases) of Marie Stopes Premium Maternity Hospital, Mirpur-10, Dhaka-1216, who came for menstrual regulation within 9 weeks (63 days) of missed period by MRM (menstrual regulation by medication), using 200mg of oral mifepristone followed by buccal misoprostol 800µg from July 2014 to December 2014.
All subjects initially received 200 mg of oral mifepristone and then were randomly assigned to receive buccal 800 μg misoprostol at 24-36 hours at health facility or at home. Some client chose self administration of second dose at home, they were given the misoprostol tablet, counsel on proper buccal technique, educated on possible side effects and informed of the safety procedure in case of an emergency. They were then followed up after 14 days with ultrasonography to confirm completion of expulsion. Treatment was considered failed if surgical evacuation was needed for any indication.
Results
Efficacy was analyzed in 100 women. Fifty percent 50% of them were <6 weeks (42 days) and 50% were between 6 weeks (43 days) to 9 weeks (63 days). Twelve patients were at 56 (8 weeks) days to 63 (9 weeks) days. Among women in whom treatment was successful, expulsion starts soon after the administration of misoprostol 70% in four hours and 30% within 24 hours in women <6 weeks of gestation and 62% in four hours and 38% within 24 hours in women >6 weeks of gestation (Table-I) . There were correlation between duration of amenorrhea and duration of bleeding. Most of the women 85% had uterine cramp, for which 20% received analgesic drugs. The pain usually started within one hour after taking of misoprostol and it lasted few hours or less. Nausia, diarrhoea and vomiting within four hours of administrating misoprostol in approximately 45%,12% and 16% of the women respectively. One woman had vasovagal reaction secondary to painful uterine cramps.
Discussion
Medical abortion using mifepristone 200mg followed by 800 μg misoprostol in the first 63 days of gestation is remarkably effective and safe 17 . Policy on MRM formulated as a strategic option for expanding safe MR services in Bangladesh 18 in 2011. Mifepristone and misoprostol are the drugs increasingly used by WHO and licensed in about 150 countiers 19 . These drugs are convenient than MR, because it is given orally with good good compliances. These drugs are inexpensive and can be stored at room temperature. The regimen used in this study appears to result in success rates that are higher (98%) in case of women <42 days gestation than that group who have had amenorrhea up to 63 days (94%) which is almost similar (95.7%) to a study in Bangladesh 20 and a study in Australia 21 where the success rate is 96.5%.
Intensity of uterine cramps after administration of misoprostolis comparatively more in women who had amenorrhea more than 42 days. The apparent decrease in the duration of bleeding in the women <6 weeks of gestation is encouraging.
In this study, no infection was reported. Infection following medical termination of pregnancy is reported to occur in 0.02%-0.92% of cases 23 . Death resulting from infection and fatal toxic shock after medical abortion with mifepristone is a known, but very rare 24 , risk (1.1/1000,000). Although the Royal
College of Obstetricians and gynecologists (RCOG) recommends universal prophylactic antibiotics effective against C. trachomatis and anaerobes to reduce infection after medical abortion, the WHO
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does not. The sides effects of two drugs neither more frequent nor more severe but slightly higher in women >6 weeks of amenorrhoea. Regarding side effects mifepristone did not give any serious side effects. Few clients had nausea, vomiting and diarrhoea within of two drugs neither more frequent nor more severe but slightly higher in women >6 weeks of pregnancy.
However, caution should be exercised in using this agent in women at risk for cardiovascular accidents. This study also found higher risk of medical abortion failure rates that had a high proportion in >42 days of gestation (6%) and it is 4% higher than those gestational age <42 days which are almost similar to other studies 20-22 . However higher risk of ongoing pregnancy in these group did not found. Overall risk of medical abortion failure in both groups seems reasonable. Moreover, prompt confirmation of completeness of the abortion by clinical assessment and routine ultrasound may enhance women's satisfaction with the procedure. This study observed no evidence that allowing women to take misoprostol at home increased abortion failure rate or serious complications. Most women preferred this option and it is presumably substantially more efficient for the health care system than requiring patients to return to the provider for administration of the prostaglandin 17 .
Conclusion
In the study reported here that for the termination of pregnancy, in women who had amenorrhea for less than 42 days (<6 weeks) is more successful as well as well tolerated than women had pregnancy between 43 days (>6 weeks) to 63 days (9 weeks). In spite of satisfactory results reported here, we wish to emphasize that the abortion procedure should continue to be medically supervised.
